Kok Thay Lim

Part of Genting Hong Kong Ltd., MV Werften Holdings Ltd. is a holding British company that operates subsidiaries engaged in ship building activities. The company is based in London, UK and was founded in 2016.

Part of Genting Malaysia Bhd., Genting International Investment Properties (UK) Ltd. provides real estate investment services. The company is based in Birmingham, UK and was founded in 2008.

Part of Great Canadian Gaming Corp., Coastbright Ltd. is a British company that operates gambling and betting activities. The company is based in London, UK. on March 22, 2019 for $45.23 million. The company was founded in 2004. Coastbright was acquired by Sonco Gaming, Inc. from Genting Malaysia Bhd.

Genting International (UK) Ltd. provides gambling and betting activities. The company was founded in 2003 and is located in London, GB

Part of Genting Malaysia Bhd., Genting UK Plc provides gambling and betting services. The company is based in Birmingham, UK. Mark Sergeant has been the CEO of the British company since 2016.

Part of Great Canadian Gaming Corp., Coastbright Ltd. is a British company that operates gambling and betting activities. The company is based in London, UK. on March 22, 2019 for $45.23 million. The company was founded in 2004. Coastbright was acquired by Sonco Gaming, Inc. from Genting Malaysia Bhd.

Part of Genting Malaysia Bhd., Genting International Investment (UK) Ltd. operates as an acquisition vehicle for Genting International Plc. The company is based in Birmingham, UK and was founded in 2006.

Genting International (UK) Ltd. provides gambling and betting activities. The company was founded in 2003 and is located in London, GB

Part of Genting Malaysia Bhd., Genting International Investment Properties (UK) Ltd. provides real estate investment services. The company is based in Birmingham, UK and was founded in 2008.

Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ.

Part of Genting Malaysia Bhd., Genting International Investment Properties (UK) Ltd. provides real estate investment services. The company is based in Birmingham, UK and was founded in 2008.

Part of Great Canadian Gaming Corp., Coastbright Ltd. is a British company that operates gambling and betting activities. The company is based in London, UK. on March 22, 2019 for $45.23 million. The company was founded in 2004. Coastbright was acquired by Sonco Gaming, Inc. from Genting Malaysia Bhd.

Genting International (UK) Ltd. provides gambling and betting activities. The company was founded in 2003 and is located in London, GB

TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore.

TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore.

Viridos, Inc. develops and commercializes genomic-driven solutions and products. The firm's offerings are designed for application in solutions such as human health, food, water production, and environment. The company was founded by J. Craig Venter, Hamilton O. Smith, David C. Kiernan and Juan Enriquez-Cabot in February 2005 and is headquartered in La Jolla, CA.

Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ.

Kien Huat Realty Sdn. Bhd. engages in real estate development company. The company is headquartered in Kuala Lumpur, Malaysia.

TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore.

TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore.

TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore.

Part of Genting Bhd., DNAe Group Holdings Ltd. is a healthcare company based in London, UK. DNAe is commercializing its pioneering semiconductor sequencing technology for healthcare applications, including infectious disease and cancer testing and monitoring. The British company is developing Lidia-seq™, a user-friendly, direct-from-specimen platform that performs genomic analysis on a microchip, to provide actionable information to clinicians. DNAe's initial focus is on infectious disease diagnostics, where speed and DNA-specific information can make the difference between life and death. The company's major shareholder is Genting Berhad, a Malaysian-based investor with a growing portfolio of investments in cutting-edge life sciences companies. The company was founded in 2003 by Christofer Toumazou. The CEO is Samuel Reed.

TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore.

Part of Genting Malaysia Bhd., Resorts World Ltd. is a premier luxury resort located in Douglas, UK. Developed by Genting Berhad, a publicly traded Malaysian corporation registered with the Nevada Gaming Commission, the $4.30 billion resort offers exceptional service, exquisite design, and unparalleled amenities. The fully integrated resort features over 3,500 guest rooms and suites, a state-of-the-art fully cashless casino floor, a 5,000 capacity theatre, distinct day and nightlife venues, a curated retail collection, a stunning spa and wellness center, and over 50 food and beverage offerings from across the globe. Resorts World is affiliated with integrated resorts in the US, Malaysia, Singapore, and the Philippines, and is being developed by approximately 2,200 construction workers on-site each day at the 88-acre site. The property will be a tech-forward, innovative, and inclusive resort that stands on the pillars of elevated service, harmony, loyalty, and luxury.

Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ.

TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore.

Viridos, Inc. develops and commercializes genomic-driven solutions and products. The firm's offerings are designed for application in solutions such as human health, food, water production, and environment. The company was founded by J. Craig Venter, Hamilton O. Smith, David C. Kiernan and Juan Enriquez-Cabot in February 2005 and is headquartered in La Jolla, CA.

Part of Genting Bhd., DNAe Group Holdings Ltd. is a healthcare company based in London, UK. DNAe is commercializing its pioneering semiconductor sequencing technology for healthcare applications, including infectious disease and cancer testing and monitoring. The British company is developing Lidia-seq™, a user-friendly, direct-from-specimen platform that performs genomic analysis on a microchip, to provide actionable information to clinicians. DNAe's initial focus is on infectious disease diagnostics, where speed and DNA-specific information can make the difference between life and death. The company's major shareholder is Genting Berhad, a Malaysian-based investor with a growing portfolio of investments in cutting-edge life sciences companies. The company was founded in 2003 by Christofer Toumazou. The CEO is Samuel Reed.

Dream Cruises Management Ltd. engages in ship operation. The company was founded on July 8, 2015 and is headquartered in Hong Kong.

Wider SRL engages in the production and distribution of yachts. Its product include superyachts and express cruisers. The company was founded by Tilli Antonelli in April 2010 and is headquartered in Ancona, Italy.

Crystal Cruises, Inc. provides tours and travels. It operates two luxury ships, the 940-guest Crystal Symphony and the 1,080-guest Crystal Serenity. The company operates cruises to the Mediterranean, Northern and Western Europe, Asia and South America. Crystal Cruises was founded in 1988 and is located in Los Angeles, CA.

Viridos, Inc. develops and commercializes genomic-driven solutions and products. The firm's offerings are designed for application in solutions such as human health, food, water production, and environment. The company was founded by J. Craig Venter, Hamilton O. Smith, David C. Kiernan and Juan Enriquez-Cabot in February 2005 and is headquartered in La Jolla, CA.

Viridos, Inc. develops and commercializes genomic-driven solutions and products. The firm's offerings are designed for application in solutions such as human health, food, water production, and environment. The company was founded by J. Craig Venter, Hamilton O. Smith, David C. Kiernan and Juan Enriquez-Cabot in February 2005 and is headquartered in La Jolla, CA.

Part of Genting Hong Kong Ltd., MV Werften Holdings Ltd. is a holding British company that operates subsidiaries engaged in ship building activities. The company is based in London, UK and was founded in 2016.

Dream Cruises Management Ltd. engages in ship operation. The company was founded on July 8, 2015 and is headquartered in Hong Kong.

TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore.